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Aflatoxins are a group of highly toxic mycotoxins with high carcinogenicity that are
commonly found in foods. Aflatoxin B1 (AFB1) is the most toxic member of the aflatoxin
family. A recent study reported that AFB1 can induce autophagy, but whether AFB1 can
induce extracellular traps (ETs) and the relationships among innate immune responses,
reactive oxygen species (ROS), and autophagy and the ETs induced by AFB1 remain
unknown. Here, we demonstrated that AFB1 induced a complete autophagic process
in macrophages (M8) (THP-1 cells and RAW264.7 cells). In addition, AFB1 induced the
generation of M8 ETs (METs) in a dose-dependent manner. In particular, the formation
of METs significantly reduced the AFB1 content. Further analysis using specific inhibitors
showed that the inhibition of either autophagy or ROS prevented MET formation caused
by AFB1, indicating that autophagy and ROS were required for AFB1-induced MET
formation. The inhibition of ROS prevented autophagy, indicating that ROS generation
occurred upstream of AFB1-induced autophagy. Taken together, these data suggest
that AFB1 induces ROS-mediated autophagy and ETs formation and an M1 phenotype
in M8.
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INTRODUCTION
Aflatoxins are a group of mycotoxins that are secondary metabolites of Aspergillus flavus and
Aspergillus parasiticus (Kasoju et al., 2012). The commodities contaminated by aflatoxins range
from daily foodstuffs to crops. Aflatoxins can enter daily life easily, especially when the humidity
is high. Aflatoxins have high toxicity and carcinogenicity. The most toxic member of the aflatoxin
family is aflatoxin B1 (AFB1). AFB1 contributes to human hepatocellular carcinoma (Daly et al.,
2000). There are few reports examining the relationship between AFB1 and the innate immune
response.
Macrophages (M8) are found in various tissues and play a crucial role in both the innate and
adaptive immune systems. They are capable of recognizing and engulfing microbial pathogens or
their toxins through phagocytosis. Lots of research papers on the effect of AFB1 on macrophages
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were published from 1970s (Michael et al., 1973; Richard and
Thurston, 1975) until recent years (Bianco et al., 2012; Bruneau
et al., 2012). And these results showed that macrophages were
participate in dealing with AFB1 toxic response. Therefore,
M8 are the first line of defense against invasion (Plowden
et al., 2004; Liu et al., 2014; Fejer et al., 2015). To address
phagocytosed microbes, M8 combine oxidative, and non-
oxidative microbicidal mechanisms; however, these classical
mechanisms are not adequate for microbes that have evolved
various strategies that interfere with phagocytosis (Lloberas and
Celada, 2002; Liu et al., 2014).
Autophagy is an essential intracellular process in which
cytoplasmic components are delivered to the autophagosomes
and lysosomes for degradation (Mihalache and Simon, 2012;
Wirawan et al., 2012). Autophagy plays an essential role
in the innate immune system in defense against viral and
bacterial infection (Takenouchi et al., 2009) or toxins (Gutierrez
et al., 2007). The classic intracellular signaling mechanism of
autophagy relies on two ubiquitin-like conjugation systems
involving the autophagy-related genes Atg7–Atg12–Atg5
or Atg4–Atg7–Atg8. Atg6 (Beclin-1 in mammals) plays an
important role in the two systems by forming an early complex
containing class III phosphoinositide 3-kinase, followed by
autophagosome formation (Yuan et al., 2012). In addition,
MEK/ERK is an important signaling pathway regulating
autophagy via regulation of Beclin-1 (Wang et al., 2009).
Reactive oxygen species (ROS) have also been suggested to
positively regulate autophagy in phagocytic cells (Huang et al.,
2009). A recent study reported that AFB1 can induce autophagy
and ROS (Paul et al., 2015).
A phagocytosis-independent innate immune mechanism
known as extracellular traps (ETs) has been recognized. Many
innate effector cells use this mechanism, including neutrophils,
mast cells, eosinophils and M8. ETs are fiber-like extracellular
structures involved in the response to infections or toxins (Liu
et al., 2014). ETs underlie a novel type of cell death also
named ETosis. Extracellular DNA (eDNA), elastase, histone,
and myeloperoxidase (MPO) are the components of ETs (Chow
et al., 2010; Liu et al., 2014). NADPH oxidase (Nox2)-dependent
(such as phorbol 12-myristate 13-acetate (PMA)-induced ETs) or
NOX2-independent (such as ionomycin-induced ETs) oxidative
bursts have been reported to activate ETosis (Remijsen et al.,
2011). ETs contribute to the capture of bacteria, fungi or their
toxins and provide a site for the accumulation of antimicrobial
molecules to kill microbes and degrade toxins (Brinkmann et al.,
2004; Fuchs et al., 2007).
Macrophage activation has a variety of phenotypes.
Macrophage polarization is a classic phenomenon commonly
referred to as classically (M1) and alternatively (M2) activated
macrophages (Liu et al., 2015). M1 macrophages can produce
pro-inflammatory mediators such as interleukin (IL)-β, tumor
necrosis factor (TNF)-α, and IL-6 to mediate antimicrobial
and antitumour immunity. However, M2 macrophage release
anti-inflammatory molecules such as IL-10, transforming growth
factor (TGF)-β1 and IL-4 and play a role in parasite containment
and wound healing (Cao et al., 2015). The expression levels
of CD80, CD86, iNOS, and CCR7 are much higher in M1
macrophages, whereas the expression levels of CD163, Arg-1,
and CD206 are much higher in M2 macrophages (Cao et al.,
2015; Liu et al., 2015; Nandakumar et al., 2016).
Previous reports investigating AFB1 have mainly focused on
its toxicity and carcinogenicity. It has also been suggested that
AFB1 can induce the generation of intracellular ROS such as
superoxide anion (O2•−), hydroxyl radical (HO•), and hydrogen
peroxide (H2O2) in mammalian cells (Sohn et al., 2003; Towner
et al., 2003). In this study, we address whether autophagy and ETs
can be induced by AFB1 and the possible relationship, function
and mechanism among ROS, autophagy and ETs under AFB1
treatment in M8.
MATERIALS AND METHODS
Antibodies, Chemicals, Plasmids, and
AFB1
The primary antibodies used for western blotting and
immunofluorescence (anti-elastase antibody, anti-histone
H3 antibody, anti-myeloperoxidase antibody, anti-CCR7
antibody, anti-CD163 antibody, anti-CD86 antibody, anti-
CD206 antibody), anti-iNOS antibody, anti-Arg-1 antibody,
and the antibodies of flow cytometry (mouse anti-human
CCR7-FITC, mouse anti-human CD86-FITC, mouse anti-
human CD163-PE, and mouse anti-human CD206-PE) in
this study were all purchased from Cell Signaling Technology
(Massachusetts, USA). Both horseradish peroxidase-labeled goat
anti-rabbit and anti-mouse secondary antibodies were obtained
from Beyotime (Jiangsu, China). The immunofluorescence
secondary antibodies were obtained from Biolegend (San
Diego, USA). Other chemicals were purchased from Dingguo
Changsheng (Beijing, China). The plasmids used in our study
were from Escherichia coli. AFB1 (purity > 98%) was purchased
from Sigma (Missouri, USA).
Cells, Cell Culture, and Transfection
THP-1 cells and RAW264.7 cells were obtained from ATCC
(Maryland, USA). THP-1 cells were maintained in RPMI 1640
medium, and RAW264.7 cells were maintained in DMEM. Both
media were supplemented with 10% fetal bovine serum (FBS).
All cell culture reagents were purchased from Gibco Laboratories
(Gibco, NY, USA). The cells were incubated at 37◦C and 5%
CO2. Differentiation of THP-1 cells into M8-like cells was
induced with 16 nM PMA (Sigma, Missouri, USA). For western
blotting, cells were incubated in 6-well flat-bottom plates (1× 106
cells/well). For fluorescence microscopy, cells were incubated
in 24-well glass-bottom plates (2 × 105 cells/well). For some
experiments, RAW264.7 cells were transiently transfected with
GFP-LC3, RFP-LC3, or RFP-GFP-LC3 plasmid.
Treatment with AFB1
AFB1 was diluted with cell culture medium to concentrations
from 0.03 to 2µM. Cells were cultured in serum-free and
antibiotic-free RPMI 1640 or DMEM medium for 12 h before
treatment with different concentrations of AFB1 for 1.5 h. AFB1
at a concentration at 0.25µM was added to cells cultured under
identical conditions for 0, 10, 30, 60, 90, 180, 360, or 720 min.
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Cell Viability Assay
After counting, cells at a density of 2 × 104/ml were cultured in
a 96-well cell culture plate (Costar) with 200µl of RPMI 1640
per well. The cells were stimulated with 0.25µM AFB1 at 37◦C
for 2 h in the presence of 5% CO2, followed by the addition of
10µL/well CCK-8 (Cell Counting Kit-8, Dojindo Laboratories,
Kumamoto, Japan) solutions. The plates were then incubated for
2 h in the dark. The cells without AFB1 in medium alone served
as positive controls. Then, the absorbance of the samples at 450
nm was measured.
Fluorescence Microscopy
Both LC3 puncta and M8 extracellular trap (MET) generation
were visualized by fluorescence microscopy. For the former, cells
were grown in 24-well glass-bottom cell-culture dishes (Nest,
Jiangsu, China). Following transfection with GFP-LC3, GFP-
LC3, or RFP-GFP-LC3 plasmid for 12 h, the cells were treated
with AFB1 at different concentrations for 2 h, and then LC3
puncta were observed under an Olympus BX53 fluorescence
microscope (Olympus, Tokyo, Japan) with a 20 × objective lens.
For the MET generation study, cells were grown in 24-well
glass-bottom cell culture dishes in serum-free and antibiotic-
free medium for 12 h. The cells were then exposed to different
concentrations of AFB1 for 2 h. The cells were stained with
5µM SYTOX Orange (Sigma, Missouri, USA) for 10 min
and then stained with 1µM Hoechst 33342 (Sigma, Missouri,
USA) for 5 min. To study the components of the METs, after
incubation, the slides were fixed with 4% paraformaldehyde
solution for 30 min at 4◦C. Blocking was performed with
5% BSA for 1 h at room temperature (RT). After washing
three times, the slides were incubated with primary antibody
at 4◦C overnight. After washing three times, the slides were
incubated with the secondary antibody for 1 h at RT. To
label the DNA, the cells were incubated with Hoechst 33342
(1µM) for 5 min. Images were collected using fluorescence
microscopy.
Western Blotting
Cells treated with AFB1 were harvested in cold PBS and
centrifuged at 3,000 g for 5 min at 4◦C. The collected cells
were incubated on ice with RIPA lysis buffer (Sigma, Missouri,
USA) containing 1 mM PMSF (Sigma, Missouri, USA) for
10 min. The supernatant of the lysates was obtained by
centrifugation at 12,000 g for 10 min at 4◦C. A BCA protein
assay kit (Beyotime, Jiangsu, China) was used to quantify
the concentration of protein. Equal amounts of protein were
separated on a 15% polyacrylamide gel and transferred onto
polyvinylidene fluoride (PVDF) membranes (Beyotime, Jiangsu,
China). The membranes were blocked for 2 h in blocking
buffer (5% non-fat milk, 0.1% Tween 20 and TBS) and
incubated with primary antibodies at 4◦C overnight, followed
by the peroxidase-conjugated secondary antibody for 2 h.
The corresponding bands were detected using an enhanced
chemiluminescence detection kit (Beyotime, Jiangsu, China). The
images were collected by a CanoScan LiDE 100 scanner (Canon,
Tokyo, Japan). Protein blots were measured with software
ImageJ.
Detection of Cytosolic ROS
Dihydrorhodamine (DHR) 123 (Sigma, Missouri, USA), a
fluorescent indicator of cytosolic ROS, was used to detect
cytosolic ROS. Cells were preloaded with 1µM DHR 123 for 20
min without light. Then, the cells were pretreated with DPI and
stimulated with the indicated reagents. The results were obtained
using a plate reader.
Flow Cytometry
Cell staining and flow cytometer analysis were performed
as described (Mandal et al., 2011). Briefly, differentiated M1
and M2 macrophages were characterized by staining with the
following antibodies: mouse anti-human CCR7-FITC, mouse
anti-human CD86-FITC, mouse anti-human CD163-PE, and
mouse anti-human CD206-PE. The samples were detected with
a FACSCalibur flow cytometer (BD Biosciences, San Jose, CA).
The data acquired were analyzed with FlowJo (Treestar Software,
Ashland, OR, USA).
Degradation of AFB1
AFB1 degradation was conducted as previously described with
some modifications (Brinkmann et al., 2004). Briefly, cells
were seeded in 24-well flat-bottom plates and treated with
cytochalasin D for 20 min. Culture medium without cells was
added to the control well. The DPI-pretreated cells were then
exposed to the indicated reagents for 8 h. For autophagy, cells,
and Atg7-silenced cells were seeded in 24-well flat bottom
plates and treated with AFB1 for 8 h. AFB1 degradation was
detected using the RIDASCREEN AFB1 30/15 enzyme-linked
immunosorbent assay (ELISA; R Biopharm) in accordance with
the manufacturer’s instructions.
Statistical Analysis
All results were expressed as the mean ± SD. Group means were
compared using one-way ANOVA with Bonferroni adjustment
using GraphPad Prism version 5.0b software to determine
statistical differences. P-values of 0.05 or less were considered
statistically significant.
RESULTS
AFB1 Induced a Time- and
Dose-Dependent Autophagic Response
To investigate whether AFB1 induced autophagy, we transfected
the GFP-LC3 plasmid into RAW264.7 cells. Following successful
transfection, RAW264.7 cells were treated with AFB1 for 2 h.
We also treated the transfected cells with the autophagy activator
rapamycin (Rapa, 5µM) or the inhibitor wortmannin (100
nM). The results obtained by fluorescence microscopy showed
that there was a significant increase in LC3 puncta in most
AFB1-treated RAW264.7 cells. Rapa also induced an increase
in LC3 puncta, whereas wortmannin pretreatment significantly
decreased the LC3 puncta in rapamycin- and AFB1-treated cells
(Figures 1A,B). This result suggested that AFB1 might induce an
autophagic response.
To further confirm the autophagy induced by AFB1, western
blotting was used to assay the LC3 levels of AFB1-treated
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FIGURE 1 | AFB1 induced a time- and dose-dependent autophagic response. (A) RAW264.7 cells were transfected with GFP-LC3 plasmid for 12 h. The cells
were pretreated with Rapa (5µM, 12 h) and wortmannin (100 nM, 1 h) and then treated with AFB1 (0.25µM) for 2 h. Scale bars = 20µm. (B) The percentage of
GFP-LC3 puncta cells was calculated. ***P < 0.001 compared with the control groups; ###P < 0.001 compared with Rapa and AFB1. (C,D) RAW264.7 cells and
THP-1 cells were pretreated with 5µM Rapa for 12 h and then treated with 0.25µM AFB1 for different times. (G,H) The two cell lines were similarly treated with Rapa
and subsequently exposed to different concentrations of AFB1 for 1.5 h. (E,F, I,J) Western blotting was conducted to assay the level of LC3. The ratio of
LC3-II/GAPDH was calculated. *P < 0.05, **P < 0.01, ***P < 0.001 compared with the control groups in the same cell line. The data are representative of three
experiments with similar results.
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M8 (THP-1 and RAW264.7). THP-1 and RAW264.7 cells
were incubated in 6-well flat-bottom plates and treated with
AFB1 or Rapa at concentrations of 0.03–2µM for 7 time
points (10–720 min). The results showed that the ratio of LC3-
II/GAPDH was significantly increased in AFB1-treated THP-1
and RAW264.7 cells compared with untreated cells in a time-
dependent (Figures 1C–F) and dose-dependent manner, and the
expression of LC3 reached its peak when cells were treated with
AFB1 for 1µM (Figures 1G–J). These data confirmed that AFB1
could induce autophagy in M8 cells.
AFB1 Induced a Complete Autophagic
Process
Although AFB1 induced autophagy, whether it was a complete
process was unclear. To examine this possibility, RAW264.7 cells
were transfected with RFP-GFP-LC3 plasmid and treated with
AFB1. The GFP moiety of this tandem autophagosome marker
is sensitive to lysosomal proteolysis and quenching in acidic pH,
whereas RFP is not. Therefore, the green fluorescent component
of the composite yellow fluorescence of this RFP-GFP-LC3
reporter is lost after autophagosome fusion with lysosomes (Sun
et al., 2012). Our results showed that for the AFB1-treated
groups and the groups pretreated with chloroquine (CQ), the
AFB1-treated groups contained more green, and red LC3 puncta
than the control groups. Most importantly, the number of red
puncta was significantly higher than the number of green puncta
(Figures 2A,B), indicating that some green puncta had vanished
during the autophagic process and suggesting that AFB1 induces
a complete process.
We also measured the degradation of the polyubiquitin-
binding protein p62/sequestosome 1 (SQSTM1), a marker for
the autophagy-mediated protein degradation pathway (Pei et al.,
2014). Using different concentrations of AFB1 to assess THP-
1 cells and RAW264.7 cells, we found that the levels of the
SQSTM1 protein decreased with increasing AFB1 concentration
(Figures 2C,D). This result is consistent with a previous
report that the degradation of SQSTM1 indicated a complete
autophagic response (Pei et al., 2014). In addition, we treated
THP-1 cells and RAW264.7 cells with CQ, a lysosomotropic
agent that inhibits autophagosome fusion with lysosomes and
therefore suppresses autophagic degradation. Our results showed
that LC3-II accumulated upon CQ treatment (Figures 2E–H),
indicating that autophagosome flux and the degradation of
LC3-II by lysosomal proteolysis was inhibited. Moreover, the
level of LC3-II was obviously higher after treatment with the
combination of AFB1 and CQ compared with AFB1 treatment
alone (Figures 2E–H), demonstrating that autophagy induced
by AFB1 included the process of the fusion of autophagosomes
with lysosomes. Taken together, these data suggested that
AFB1 induced a complete autophagic process. To further
corroborate whether AFB1-induced autophagy is a cell death-
mediating mechanism, we first used a specific shAtg7 plasmid
to knockdown the expression of Atg7 (Autophagy related genes)
(Figure 2I). The cell viability of AFB1-treated RAW264.7 cells
transfected with the shAtg7 plasmid was significantly increased
compared with cells transfected with the negative shRNAplasmid
and non-transfected cells (P < 0.05) (Figure 2J). This result
confirmed that the AFB1-induced autophagic response was a cell
death-mediating mechanism. To study the role of autophagy, the
AFB1 content was detected by ELISA. ELISA revealed that the
content of AFB1 (the original treatment concentration of AFB1
was 2µM) significantly decreased after 8 h incubation with non-
transfected or negative shRNA cells compared with Atg7-silenced
cells under AFB1 treatment (P < 0.001) (Figure 2K).
The Autophagy Response Induced by AFB1
Was MEK/ERK-Dependent and
Upregulated Beclin-1
To analyze the possible mechanism of the autophagic response
induced by AFB1, we detected the expression level of Beclin-1
in AFB1-treated THP-1 and RAW264.7 cells. AFB1 treatment
increased the expression of Beclin-1 in the two cell lines, and
the expression of Beclin-1 was maximal when the cells were
treated with AFB1 for 1 h (Figures 3A,B). This result suggested
that the AFB1-induced autophagic response might be mediated
by Beclin-1. Next, we used a specific shBeclin-1 plasmid to
knockdown the expression of Beclin-1 (Figure 3C) to further
corroborate the correlation of Beclin-1 and AFB1-induced
autophagy. RPF-LC3 puncta were significantly decreased in
AFB1-treated RAW264.7 cells transfected with the shBeclin-
1 plasmid compared with the group transfected with the
negative shRNA plasmid and the control groups (P < 0.05)
(Figures 3D,E). This result verified that the AFB1-induced
autophagic response was mediated by Beclin-1.
Additionally, our western blotting analysis showed that AFB1
treatment significantly increased the phosphorylation of MAP
kinase kinase 1/2 (MEK1/2) and extracellular signal-regulated
kinases 1/2 (ERK1/2), and treatment with AFB1 in combination
with the MEK inhibitor PD98059 markedly abolished the
expression of MEK1/2 and ERK1/2 in THP-1 and RAW264.7
cells (Figures 3F,G). To further verify whether the activation
of MEK/ERK was related to AFB1-induced autophagy, THP-1,
and RAW264.7 cells were also treated with AFB1 together with
the MEK inhibitor PD98059. Western blotting results for LC3
showed that the inhibition of MEK/ERK by PD98059 abrogated
the autophagic response (Figure 3H). Moreover, the fluorescence
microscopy results also showed that inhibiting MEK/ERK by
PD98059 suppressed the punctate GFP-LC3 pattern induced by
AFB1 treatment (Figures 3I,J). These data indicated that the
autophagy response caused by AFB1 is MEK/ERK-dependent.
Furthermore, to explore the order of precedence of Beclin-
1 and MEK/ERK in the autophagy response induced by AFB1,
we assayed the expression of Beclin-1 in RAW264.7 cells
treated with AFB1 in combination with the MEK inhibitor
PD98059. The inhibition of MEK/ERK activation abrogated the
up-regulation of Beclin-1 caused by AFB1 treatment (Figure 3K).
This result suggested that the activation ofMEK/ERK in response
to autophagy stimuli induced by AFB1 treatment upregulated
Beclin-1.
AFB1 Induced the Generation of METs
To explore whether AFB1 induced the generation of ETs in
M8, THP-1 cells were incubated with different concentrations
of AFB1 and then stained with Hoechst 33342 (1µM) and
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FIGURE 2 | AFB1 induced a complete autophagic process. (A) RAW264.7 cells were transfected with tandem GFP-RFP-LC3 plasmid for 12 h. Cells were
pretreated with or without CQ, followed by treatment with AFB1 (0.25µM) for 2 h and observation by fluorescence microscopy. Scale bars = 20µm. (B) The
percentage of GFP-RFP-LC3 puncta cells was calculated. ***P < 0.001 compared with the control groups; ###P < 0.001 compared with AFB1. (C,D) RAW264.7
cells and THP-1 cells were incubated in 6-well flat-bottom plates (1 × 106 cells/well) and cultured in serum-free and antibiotic-free medium for 12 h. Following
(Continued)
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 6 February 2017 | Volume 7 | Article 53
An et al. AFB1 Induced Autophage and METs
FIGURE 2 | Continued
treatment with Rapa (5µM, 12 h), the cells were treated with different concentrations of AFB1 from 0.03 to 2µM for 1.5 h. Western blotting of SQSTM1 was
performed. (E,F) RAW264.7 cells and THP-1 cells were pretreated with CQ (20µM) for 1 h and subsequently exposed to AFB1 (0.25µM) for 1.5 h. Western blotting
for LC3 was then performed. (G,H) The ratios of p62/GAPDH and LC3-II/GAPDH were calculated. *P < 0.05, ***P < 0.001 compared with the control groups of the
same cell line; ##P < 0.01, ###P < 0.001. (I) Western blotting of Atg7 in RAW264.7 cells with or without knockdown treatment. (J) Cell viability was estimated
using the Cell Counting Kit-8 (CCK-8) assay ***P < 0.001. (K) Non-transfected RAW264.7 cells, Atg7-silenced cells, and cells transfected with the shRNA negative
control cells were incubated in 24-well plates (2 × 105 cells/well) with serum-free medium for 12 h, followed by treatment with AFB1 (2µM) for 8 h. We performed
AFB1 ELISA to determine the AFB1 content using an ELISA kit. ***P < 0.001. The data are representative of three experiments with similar results.
SYTOX Orange (5µM), followed by image collection. The
results showed that AFB1 treatment induced highly reticulated
structures containing extracellular DNA in a concentration-
dependent manner (Figure 4A), similar to the results of
PMA treatment. However, few METs formed when M8 were
incubated without AFB1 (Figure 4A). This result suggested
that AFB1, as an exogenous toxin, was recognized through
ETs by phagocytes. In addition, we found that elastase (anti-
elastase antibody) (Figure 4B) and MPO (anti-myeloperoxidase
antibody) (Figure 4C) colocalized with histone (anti-histone H3
antibody) and eDNA, respectively. These results demonstrated
that elastase, MPO, histone, and eDNA were components of the
AFB1-induced METs.
Autophagy and ROS are Required for
AFB1-induced MET Formation
We also investigated the possible mechanisms involved in
MET formation induced by AFB1. First, we assessed the
relationship between ROS and MET formation. The NOX2
inhibitor DPI (50µM) inhibited MET formation induced
by AFB1 or PMA (Figures 5A,B). This result demonstrated
that AFB1-induced METs were NOX2-dependent, similar to
PMA. Next, we used a fluorescent indicator of cytosolic ROS
(dihydrorhodamine or DHR 123) (Douda et al., 2015) with
a plate reader assay to detect cytosolic ROS production in
AFB1-treated THP-1 cells. AFB1 or PMA treatment triggered
a large increase in cytosolic ROS production (Figure 5C),
whereas DPI significantly inhibited the enhancement of AFB1-
or PMA-induced cytosolic ROS production (Figure 5C). These
results demonstrated that the AFB1-induced MET formation
was dependent on the ROS produced by NOX2. To further
examine the role of AFB1-induced autophagy in MET formation,
we used the PI3K inhibitor wortmannin to inhibit autophagy.
Pretreatment with wortmannin abolished LC3B-I to LC3B-
II conversion, as expected (Figure 5D), and inhibited MET
formation (Figures 5E,F). Thus, either inhibition of autophagy
or ROS prevented MET formation by AFB1, indicating that
autophagy and ROS are required for AFB1-induced MET
formation.
ROS Generation is Required for the
Activation of AFB1-Induced Autophagy
Because both autophagy and ROS are required for AFB1-induced
MET formation, we further assessed the possible relationship
between ROS and autophagy induced by AFB1 in M8. We
detected the levels of cytosolic ROS and LC3 expression in
AFB1-treated RAW264.7 cells with or without DPI. PMA,
which induces ROS generation, was used as a positive control
agent. DPI pretreatment significantly decreased the ratio of
LC3-II/GAPDH under AFB1 treatment (P < 0.05), similar
to the results for PMA (Figure 6A), whereas AFB1 induced
cytosolic ROS production in a dose- and time-dependent manner
(Figures 6B,C). Pretreatment with 100 nM wortmannin did
not affect PMA- or AFB1-induced cytosolic ROS production
(Figure 6D). Thus, inhibition of ROS prevented autophagy,
indicating that ROS generation occurs upstream of AFB1-
induced autophagy.
MET Formation Reduced the AFB1 Content
A previous report determined that ET formation by phagocytes
not only traps and kills microorganisms but also degrades
toxins (Brinkmann et al., 2004). Because AFB1 is sensed by
METs, we examined whether MET formation reduced the
AFB1 content. ELISA showed that the content of AFB1 (the
original treatment concentration of AFB1 was 2µM) was
significantly decreased after 8 h of incubation with RAW264.7
cells compared to incubation without cells, and PMA (16
nM) treatment significantly enhanced the degradation of AFB1
by METs (Figure 7A). In particular, the ET scavenger DPI
(50µM) significantly decreased the degradation of AFB1 by
METs (Figure 7A). Further analysis revealed a strong positive
correlation (r = 0.93) between the amount of METs and the
amount of AFB1 degraded by METs (Figure 7B and Figure S1).
We suggest that innate immune cells use ET formation to degrade
the exogenous toxin AFB1 and weaken its toxicity.
AFB1 Induced M1-Like Polarization in
RAW264.7 Cells
To investigate the effect of AFB1 on the polarization of
macrophages, we evaluated the phenotypes of Atg7-silenced
Raw 264.7 cells and non-transfected cells with or without AFB1
treatment. AFB1 treatment increased the expression of CCR7 and
CD86; which is a marker of the M1 phenotype. However, CD163
and CD206 (M2 marker) were decreased by AFB1 treatment
in non-transfected RAW264.7 cells (Figure 8A). Polarization
to M1-like polarization occurred in a dose-dependent manner.
However, Atg7-silenced cells did not exhibit a trend of M1 or M2
polarization under AFB1 treatment (Figure 8B). Additionally,
we used immunofluorescence staining to examine the phenotype
characteristics. CCR7 (M1 marker) was significantly more
expressed than CD163 (M2 marker) (Figure S2). Furthermore,
we analyzed cytokines associated with polarization in Atg7-
silenced and non-transfected cells under AFB1 treatment. The
immunofluorescence staining showed that iNOS expression was
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FIGURE 3 | The autophagy response induced by AFB1 was MEK/ERK-dependent and upregulated Beclin-1. (A,B) RAW264.7 cells and THP-1 cells were
pretreated with Rapa (5µM) for 12 h and then treated with AFB1 for different times. Western blotting was used for the Beclin-1 protein assay. The ratios of
Beclin-1/GAPDH were calculated. (C)Western blotting of Beclin-1 in RAW264.7 cells with or without knockdown treatment was conducted. (D) RAW264.7 cells were
transfected with the RFP-LC3 plasmid for 12 h and then transfected with the shRNA negative control or shBeclin-1 plasmids for 48 h before the cells were infected
with AFB1 (0.25µM) for 2 h. Fluorescence images show the induction of LC3 puncta. Scale bars = 20µm. (E) The percentage of RFP-LC3 puncta cells was
(Continued)
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FIGURE 3 | Continued
calculated. ***P < 0.001 compared with AFB1-infected cells; ###P < 0.001 compared with negative control shRNA plasmid. (F–H) RAW264.7 cells and THP-1
cells were pre-treated with the MEK/ERK inhibitor PD98059 (20µM) for 1 h and then treated with AFB1 (0.25µM) for P-ERK, P-MEK, and LC3 protein assays.
(I) RAW264.7 cells were transfected with GFP-LC3 plasmid for 12 h. The cells were pretreated with PD98059 (20µM, 1 h) and then treated with AFB1 (0.25µM) for 2
h. Scale bars = 20µm. (J) The percentage of GFP-LC3 puncta cells was calculated. ***P < 0.001 compared with the control groups; ###P < 0.001 compared with
AFB1. (K) Western blotting of Beclin-1 was performed after treatment with PD98059 (20µM, 1 h) and AFB1 (0.25µM).
FIGURE 4 | AFB1 induced the generation of METs. (A) THP-1 cells were incubated in 24-well glass-bottom plates (2 × 105 cells/well) with serum-free RPMI 1640
for 12 h. Cells were treated with PMA (16 nM) and AFB1 (2µM) at concentrations of 0.03, 0.12, 0.5, or 2µM for 2 h. METs were stained with SYTOX Orange (5 mM)
for 10 min, and nuclei were stained with Hoechst 33342 (1µM) for 5 min. (B) Histone, elastin, and eDNA colocalized. (C) Histone, myeloperoxidase, and eDNA
colocalized. The images were obtained by fluorescence microscopy with a 20× objective lens. Scale bars = 50µm.
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FIGURE 5 | Autophagy and ROS are required for AFB1-induced MET formation. (A) THP-1 cells were pre-treated with the NOX2 inhibitor DPI (50µM) for 1 h
then, PMA (16 nM) and AFB1 (0.25µM) were added to the cells for 2 h. The cells were stained with Hoechst 33342 (1µM) and then observed by fluorescence
microscopy with a 20× objective lens. Scale bars = 50µm. (B) The fluorescence intensity of extracellular DNA was detected by a plate reader. (C) For the
quantification of cytosolic ROS, THP-1 cells were incubated in 24-well plates (2 × 105 cells/well), pre-treated with DPI (50µM) for 1 h and then treated with PMA
(16 nM) and AFB1 (0.25µM). Cytosolic ROS were labeled by DHR 123 (1µM) and detected by a plate reader. The data were analyzed by Graphpad prism software
(GraphPad, San Diego). ***P < 0.001 compared with the control groups in the same cell line; ###P < 0.001 compared with the PMA and AFB1. The data are
representative of three experiments with similar results. (D) THP-1 cells were cultured in serum-free and antibiotic-free medium for 12 h. Then, cells were pretreated
with wortmannin (100 nM) for 1 h followed by AFB1 (0.25µM) for 1.5 h. Western blotting of LC3 was performed. (E) THP-1 cells were pre-treated with the autophagy
inhibitor wortmannin (100 nM) for 1 h, and then AFB1 (0.25µM) was added to the cells for 2 h. The cells were stained with Hoechst 33342 (1µM) and then observed
by fluorescence microscopy with a 20× objective lens. Scale bars = 50µm. (F) The fluorescence intensity of extracellular DNA was detected by a plate reader
***P < 0.001 compared with the control groups; ###P < 0.001 compared with the AFB1.
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FIGURE 6 | ROS generation is required for the activation of AFB1-induced autophagy. (A) RAW264.7 cells were pre-treated with the NOX2 inhibitor DPI
(50µM) for 1 h. PMA (16 nM) and AFB1 (0.25µM) were then added to the cells for 2 h and western blotting of LC3 was performed. (B,C) RAW264.7 cells were
treated with AFB1 at different concentrations and times. Cytosolic ROS were labeled by DHR 123 (1µM) and were detected by a plate reader, **P < 0.01,
***P < 0.001 compared with the control groups in the same cell line. (D) Cells were pretreated with wortmannin (100 nM, 1 h) after treatment with AFB1 (0.25µM) and
PMA (16 nM) for 2 h. Cytosolic ROS were detected by a plate reader, ***P < 0.001 compared with the control groups in the same cell line.
significantly higher than Arg-1 expression, but neither iNOS
nor Arg-1 was expressed in Atg7-silenced cells (Figure 8C).
In addition, ELISA showed that the expression of TNF-α was
higher in non-transfected cells than in Atg7-silenced cells, and
IL-10 was not significantly expressed in either non-transfected
cells or Atg7-silenced cells (Figure 8D). Taken together, these
results indicate that AFB1-treated RAW264.7 cells exhibited
a dose-dependent increase in M1 polarity and that aflatoxin-
induced autophagy affected the polarization and cytokine
responses.
DISCUSSION
AFB1 is a coumarin derivative with mutagenic, teratogenic,
and carcinogenic effects. AFB1 plays an essential role in
human hepatic and extrahepatic carcinogenesis (Puiu et al.,
2012). Most published studies have focused on the interaction
between AFB1 and hepatocytes. However, as M8 are first-
line immune cells, we hypothesized that M8 must respond to
AFB1. Whether macrophages are needed for the AFB1 toxic
response, dozens of research papers has been published to
show that the effects of AFB1 on macrophages from different
organizations of various animals (including those from human
being) in vitro and in vivo (Schlemper et al., 1991; Mohsenzadeh
et al., 2016), and effects studied of AFB1 on macrophages
included the ability of macrophage to activate AFB1 (Michael
et al., 1973; Richard and Thurston, 1975; Bianco et al., 2012;
Bruneau et al., 2012); DNA binding, adduct characterization
and metabolic activation of AFB1 catalyzed by macrophages
Steinberg et al., 1990; Schlemper et al., 1991; Donnelly et al.,
1996; immune functional impairment of macrophages by
AFB1 containing adherence potential, morphological alterations,
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FIGURE 7 | METs formation reduced the AFB1 content. (A) RAW264.7 cells were incubated in 24-well plates (2 × 105 cells/well) with serum-free medium for
12 h. Only one of the wells was pretreated with DPI (50µM) for 1 h, and then CytD was added to all of wells for 20 min, followed by treatment with AFB1 (2µM) or
PMA (16 nM) and AFB1 (2µM) for 8 h. We used the AFB1 ELISA to determine the AFB1 content through an ELISA kit. The cells were treated with AFB1 with or
without PMA, or AFB1 with or without DPI. *P < 0.05, **P < 0.01, ***P < 0.001 compared with the control groups (only cells) in the same cell line. The data are
representative of three experiments with similar results. (B) The fluorescence intensity of Extracellular DNA was detected by a plate reader. The data are representative
of three experiments with similar results.
phagocytic activity, microbiocidal activity (Mohapatra and
Roberts, 1985; Cusumano et al., 1995; Bianco et al., 2012),
NO production (Moon and Pyo, 2000), mRNA and protein
secretion levels of pro-inflammatory cytokines, cell surface
marker expression (Dugyala and Sharma, 1996; Bruneau et al.,
2012), resistance to tumor (Moon et al., 1999), and so on. All
these results suggested that macrophages are needed for the
AFB1 toxic response, and the work of macrophages is relevant
to the disease process of AFB1 intoxication. And our results
supplemented and perfected the data from other scientists in
some extent.
A recent study reported that AFB1 induced autophagy and
ROS (Paul et al., 2015). However, whether the autophagic
response induced by AFB1 is a complete process, whether
AFB1 can induce ETs, and the relationship among innate
immune responses, ROS, autophagy, and ETs induced by AFB1
remain unknown. As predicted, our results showed that AFB1
treatment triggered an autophagic response in both M8 THP-
1 and RAW264.7 cells in a dose-dependent manner (0.03–2µM)
(Figures 1G–J). MET release was also induced by AFB1 in THP-
1 cells in a dose-dependent manner (0.03–2µM) (Figure 4A). In
addition, we analyzed the possible mechanism of the three novel
innate immune responses induced by AFB1: ROS, autophagy,
and MET formation. The results reveal a new mechanism of
AFB1 recognition and treatment by phagocytes in vitro.
Autophagy is an intracellular membrane trafficking pathway
that plays an important role in controlling bacterial infection
and toxins (Ham et al., 2011; Huynh et al., 2011). Bacteria or
toxins in the cytoplasm are captured by autophagy and delivered
to autophagosomes and autolysosomes for destruction (Yuan
et al., 2012). Therefore, the final process of autophagosome
fusion with lysosomes is the most important step in the
treatment of pathogens and toxins. Thus, a complete process of
AFB1-induced autophagy is essential for M8 to address AFB1.
SQSTM1/P62, an adaptor protein, binds LC3 and ubiquitin
to facilitate autophagy of polyubiquitinated proteins and is a
marker for the autophagy-mediated protein degradation pathway
(Lam et al., 2012; Pei et al., 2014). Therefore, the down-
regulation of SQSTM1 can be used to determine if autophagy
is complete. In our study, the GFP-RFP-LC3 plasmid was
used because the GFP moiety of this tandem plasmid is
sensitive to lysosomal proteolysis and quenching in acidic pH,
whereas RFP is not (Sun et al., 2012). Our results showed that
the expression of SQSTM1 was indeed decreased in a dose-
dependent manner (Figures 2C,D). We also observed fewer
green puncta than red puncta by fluorescence microscopy,
indicating that AFB1-induced autophagy included the process of
acidification. Additionally, CQ treatment significantly increased
the level of LC3-II induced by AFB1. These results confirmed
that AFB1 induced a complete autophagic process and suggested
that autophagy plays a role in the disposal of intracellular AFB1.
However, the location of AFB1 in autophagic organelles awaits
further study.
Our analysis demonstrated that the AFB1-induced autophagic
response was mediated by Beclin-1 and was also dependent on
MEK/ERK. Using the MEK inhibitor PD98059, we observed that
the activation of MEK/ERK in response to autophagy stimuli
induced by AFB1 treatment upregulated Beclin-1. This result
was consistent with a previous report that MEK/ERK regulates
autophagy via regulating Beclin-1 (Wang et al., 2009).
Previous studies mainly focused on the ETs produced by
neutrophils and occasionally, eosinophils, or mast cells (Aulik
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FIGURE 8 | AFB1 induced M1-like polarization in RAW264.7 cells. (A) The expression levels of CD86 and CD206 in RAW264.7 cells were detected by flow
cytometry. The results are presented as the mean fluorescence intensity (MFI). ***P < 0.001 compared with the control groups of RAW264.7 cells. The data are
representative of three experiments with similar results. The histogram figure represents the comparison of the 2µM AFB1-treated group and control group. (B) CD86
and CD206 in RAW264.7 cells, Atg7-silenced cells and cells transfected with the shRNA negative control were detected by flow cytometry. The results are presented
as the mean fluorescence intensity (MFI). ***P < 0.001 compared with the control groups of RAW264.7 cells; ###P < 0.001 compared with AFB1-infected cells and
cells transfected with the negative control shRNA plasmid. The histogram figure represents the comparison of the 2µM AFB1-treated group, Atg7-silenced cells, cells
transfected with the shRNA negative control and control group. (C) iNOS, Arg-1 and eDNA colocalized, and the immunofluorescence staining shows the comparison
of the 2µM AFB1-treated Non-transfected cell group, Atg7-silenced cell group, cells transfected with the shRNA negative control group and control group. (D) TNF-α
and IL-10 secretion was measured by ELISA. ***P < 0.001 compared with the control group; ###P < 0.001 compared with the AFB1-infected cells and cells
transfected with the negative control shRNA plasmid.
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et al., 2012). Releasing nuclear DNA to form ETs has not
been reported for M8 until recently (Chow et al., 2010). Our
team has shown that peritoneal M8 (RAW264.7) release METs
after treatment with PMA (Liu et al., 2014). In this study,
we found that not only RAW264.7 cells but also THP-1 cells
produced METs in response to AFB1. In particular, our results
also indicated that MET formation significantly reduced the
AFB1 content, whereas treatment with the METs scavenger DPI
(50µM) reversed the degradation. The results therefore revealed
that phagocytes could not only recognize and treat intracellular
toxic AFB1 by autophagy but also address extracellular toxic
AFB1 through MET formation.
Two types of mechanisms are involved in the formation
of ETs: NOX2-dependent and NOX2-independent. Our results
showed that the AFB1-induced METs were NOX2-dependent,
similar to those observed for PMA, because the NOX2 inhibitor
DPI inhibited the formation of METs induced by AFB1.
Additional assays indicated that AFB1 treatment triggered a
significant increase in cytosolic ROS production in THP-1 cells
(Figure 5C). Recent studies have shown that NOX2-mediated
ROS production is related to the activation of autophagy by
microorganisms in phagocytes (Huang et al., 2009). It has been
suggested that the autophagic machinery is activated during ROS
production to counter possible oxidative burst-dependent cell
damage and death (Mitroulis et al., 2010).
The different environmental signals from different tissues,
such as injury, healing, and repair, underlie the heterogeneity
of macrophages (Ben-Mordechai et al., 2015). M1 and M2 are
the most common phenotypes of macrophages. M1macrophages
are pro-inflammatory, whereas M2 macrophages are anti-
inflammatory and reparative. Both macrophage types play
irreplaceable roles in the immune system. Thus, the polarization
of macrophages has been studied widely. In many recent
reports, granulocyte-macrophage colony stimulating factor (GM-
CSF), lipopolysaccharides (LPS) and interferon (IFN) γ were
shown to stimulate macrophages to the M1 phenotype (Brown
et al., 2012). In addition, the M2 macrophage phenotype
was stimulated by macrophage colony-stimulating factor (M-
CSF), IL-4, IL-10, IL-13, and glucocorticoid hormones (Biswas
et al., 2012). AFB1 has high toxicity and can cause hepatic
disease. Our results showed that AFB1 induced polarization
of RAW264.7 cells to the M1 phenotype in a dose-dependent
manner (Figure 8A and Supplementary Figure S2). Because
M1 macrophages are pro-inflammatory, we speculate that
AFB1 leads to liver damage by inducing M1 macrophage
polarization.
Overall, this study demonstrated that M8 could recognize or
treat a certain concentration range of the exogenous toxin AFB1
with the aid of two novel innate immune responses, autophagy
and ET formation. This study lays a foundation for deeper
research into the innate immune mechanisms and immune
control of AFB1.
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Figure S1 | METs was stained with SYTOX Orange (5 mM) for 10 min and
Hoechst 33342 (1µM) for 5 min. The images were obtained by fluorescence
microscopy with a 20 × objective lens. Scale bars = 50µm.
Figure S2 | (A) CCR7 and CD163, CD86 and CD206 with eDNA [stained with
Hoechst 33342 (1µM) for 5 min] colocate in RAW264.7 cells. The images were
obtained by fluorescence microscopy with a 20 × objective lens. Scale bars =
50µm. (B) CCR7 and CD163 in RAW264.7 cells, were detected by flow
cytometry. The results are presented as mean fluorescence intensity (MFI).
∗∗∗P < 0.001 compared with the control groups in RAW264.7 cells. (C) CCR7
and CD163 in RAW264.7 cells, Atg7-silenced cells, and cells transfected with the
shRNA negative control were detected by flow cytometry. The results are
presented as the mean fluorescence intensity (MFI). ∗∗∗P < 0.001 compared with
the control groups of RAW264.7 cells; ###P < 0.001 compared with
AFB1-infected cells and cells transfected with the negative control shRNA
plasmid. The histogram figure represents the comparison of the 2µM
AFB1-treated group, Atg7-silenced cells, cells transfected with the shRNA
negative control and control group.
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